drugset / Trial / NCT05758532

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

NCT05758532 ↗

Phase 4 Recruiting 500 enrolled Laure Pittet, MD-PhD
RandomizedFactorialOpen-labelPrevention

Summary

The goal of this clinical trial is to evaluate the off-target/non-specific effects of the measles-mumps-rubella (MMR) vaccine in children.

Timeline

Start
2023-03-17
Primary completion
2026-04
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Measles-Mumps-Rubella vaccine (MMR) Vaccine 0.5 ml Intramuscular